Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 6 | 2024 | 4878 | 0.350 |
Why?
|
Mutagenesis | 1 | 2022 | 1232 | 0.300 |
Why?
|
Mutation | 11 | 2024 | 30054 | 0.260 |
Why?
|
Isoxazoles | 2 | 2024 | 232 | 0.250 |
Why?
|
Nuclear Physics | 2 | 2014 | 75 | 0.230 |
Why?
|
Organ Specificity | 3 | 2024 | 1968 | 0.210 |
Why?
|
Autistic Disorder | 1 | 2022 | 1220 | 0.210 |
Why?
|
Neoplasms | 6 | 2024 | 22173 | 0.200 |
Why?
|
Phthalazines | 1 | 2024 | 383 | 0.200 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2024 | 245 | 0.190 |
Why?
|
Gene Amplification | 2 | 2023 | 1089 | 0.190 |
Why?
|
Music | 1 | 2024 | 245 | 0.190 |
Why?
|
Pyrazines | 2 | 2024 | 1201 | 0.180 |
Why?
|
Deoxycytidine | 2 | 2024 | 877 | 0.180 |
Why?
|
Translocation, Genetic | 2 | 2024 | 1393 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 552 | 0.170 |
Why?
|
Oncogenes | 2 | 2023 | 1222 | 0.170 |
Why?
|
Leiomyosarcoma | 1 | 2023 | 422 | 0.170 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2450 | 0.160 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 583 | 0.160 |
Why?
|
Platinum Compounds | 1 | 2019 | 95 | 0.160 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1158 | 0.150 |
Why?
|
Point Mutation | 1 | 2022 | 1595 | 0.140 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 428 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2019 | 992 | 0.130 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 601 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3639 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1745 | 0.130 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 764 | 0.120 |
Why?
|
DNA Replication | 1 | 2021 | 1418 | 0.120 |
Why?
|
Elementary Particles | 1 | 2014 | 52 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 77 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2523 | 0.110 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1745 | 0.110 |
Why?
|
Aging | 1 | 2022 | 8711 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1745 | 0.110 |
Why?
|
Transcription Factors | 1 | 2022 | 12129 | 0.100 |
Why?
|
INDEL Mutation | 2 | 2024 | 266 | 0.100 |
Why?
|
Models, Theoretical | 2 | 2014 | 3575 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2917 | 0.090 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2220 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1366 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11742 | 0.080 |
Why?
|
Genome, Human | 4 | 2023 | 4425 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2024 | 5672 | 0.080 |
Why?
|
Genomic Instability | 2 | 2024 | 709 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5821 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8552 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21017 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5305 | 0.060 |
Why?
|
Enhancer Elements, Genetic | 1 | 2022 | 1363 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12059 | 0.060 |
Why?
|
Computer Simulation | 1 | 2019 | 6241 | 0.060 |
Why?
|
Brain | 1 | 2022 | 27120 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5709 | 0.060 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 2020 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6935 | 0.060 |
Why?
|
Humans | 21 | 2024 | 761572 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9177 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9031 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16986 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9280 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4111 | 0.050 |
Why?
|
Protein Binding | 1 | 2022 | 9353 | 0.040 |
Why?
|
Nucleotides | 1 | 2022 | 454 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2024 | 743 | 0.040 |
Why?
|
Female | 10 | 2024 | 392686 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14032 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2023 | 613 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 304 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2022 | 805 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15936 | 0.040 |
Why?
|
Doxorubicin | 1 | 2023 | 2224 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2707 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2024 | 10448 | 0.030 |
Why?
|
Estrogens | 1 | 2023 | 1522 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
Embryonic Development | 1 | 2021 | 721 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2020 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 959 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2024 | 1886 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2391 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2046 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11904 | 0.030 |
Why?
|
Gene Frequency | 1 | 2021 | 3606 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 962 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2449 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4915 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2021 | 4615 | 0.030 |
Why?
|
Cell Division | 1 | 2021 | 4465 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6132 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2865 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 595 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1858 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2787 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2024 | 3677 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7213 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6864 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3517 | 0.020 |
Why?
|
Software | 1 | 2023 | 4434 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2961 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4740 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9420 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3801 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58986 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3877 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2024 | 6346 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4580 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20099 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14416 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81533 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5769 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 9489 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9463 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168467 | 0.010 |
Why?
|
Aged | 2 | 2024 | 169310 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17904 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29876 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54426 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 220920 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41493 | 0.010 |
Why?
|
Male | 2 | 2024 | 360842 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64684 | 0.010 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_